Drugs Found In Nature Stop Cancer Spread
Posted on: Saturday, 17 July 2004, 06:00 CDT
Medicines from sea and tree keep cells from multiplying
HealthDayNews --Two drugs from unlikely sources -- an ocean-growing sponge and a European evergreen tree -- apparently team up well to prevent the spread of cancer cells.
The sponge-based drug, discodermolide, works with a yew tree derivative called paclitaxel to thwart tumor cell growth, according to research published in the July 15 issue of Cancer Research.
In fact, using the drugs in combination is several times more effective than using either drug alone, concluded researchers at the University of California, Santa Barbara.
Both drugs prevent cancer spread by interfering with tumor cells' ability to divide, keeping cells stalled in a pre-division stage of growth.
Paclitaxel currently is an approved drug for the control of cancer growth, while discodermolide is undergoing phase one clinical trials.
-----
On the Net:
University of California, Santa Barbara
U.S. Centers for Disease Control and Prevention
More science, space, and technology from RedNova
Copyright © 2004 HealthDay. All rights reserved. The information contained above is intended for general reference purposes only. It is not a substitute for professional medical advice or a medical exam. Always seek the advice of your physician or other qualified health professional before starting any new treatment.
Related Articles
- Pancreatic Cancer: Researchers Find Drug That Reverses Resistance To Chemotherapy
- ZymoGenetics Presents Interim IL-21 Phase 2 Results in Renal Cell Cancer
- Preclinical Data Highlighting Potential of Retaspimycin in Treating Non-Small Cell Lung Cancer With Acquired Drug Resistance Presented By Infinity and MedImmune At AACR; Preclinical Data Also Support Evaluation of Retaspimycin in HER2-Positive Breast Can
- ZymoGenetics Initiates Phase II Renal Cell Cancer Trial
- ZymoGenetics Begins Phase 2 Trial in Renal Cell Cancer Evaluating IL-21 Combined With Nexavar(R)
- Cancer-Related Anemia Drug Warning Revised
- Use of Sequenom's MassARRAY System Leads to Significant Scientific Advances in Understanding Cancer, Diabetes and Drug-Resistant Malaria
- ZymoGenetics Begins Phase 1/2 Clinical Trial With IL-21 and Nexavar in Patients With Renal Cell Cancer
- eRx Collaborative Boosts Patient Safety With 8,000 Prescriptions Changed in June; Record Number of Electronic Prescriptions Changed As a Result of Drug-Drug and Drug-Allergy Alerts
- Indonesia's Cell Phone Market Continues Rapid Growth
 |
 |
User Comments (0)
RSS Feeds